Exagen CFO in tax sale, ESPP stock purchase
Exagen’s CFO reported a tax-withholding share sale and a smaller ESPP share purchase on September 1, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
EXAGEN INC. (XGN) reported that its Chief Financial Officer, Jeffrey G. Black, had mixed equity activity on September 1, 2026. He sold 20,614 shares of common stock at an average price of $7.2175 per share to cover tax withholding on vesting Restricted Stock Units, a transaction mandated by the company. On the same date, he acquired 1,571 shares of common stock at $3.0175 per share through the company’s Employee Stock Purchase Plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 20,614 | $7.2175 | $149K |
| Grant/Award | Common Stock F2, F3 | 1,571 | $3.0175 | $5K |
Footnotes (3)
- F1. The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person.
- F2. The reporting person is voluntarily reporting the acquisition of the common stock pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP").
- F3. Represents shares of common stock purchased through the ESPP in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Key Figures
Key Terms
Restricted Stock Units financial
Employee Stock Purchase Plan financial
Rule 16b-3(d) regulatory
Rule 16b-3(c) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Exagen (XGN) disclose for its CFO on September 1, 2026?
Were the Exagen (XGN) CFO’s September 1, 2026 transactions under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.